导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.41% | 401/1050 |
| 近一周 | 0.04% | 279/1104 |
| 近一月 | 0.32% | 116/1103 |
| 近一季 | -4.90% | 466/1092 |
| 近半年 | -0.23% | 456/1070 |
| 近一年 | 10.09% | 370/1018 |
| 近两年 | 89.83% | 245/926 |
| 近三年 | 50.83% | 261/834 |
| 成立以来 | 132.73% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.74% 540/1070 |
12.25% 514/1101 |
- - |
- - |
| 2025 | 39.98% 326/1065 |
5.77% 357/1014 |
7.56% 179/1038 |
18.51% 649/1050 |
3.83% 199/1065 |
| 2024 | 4.02% 464/1011 |
-5.25% 578/960 |
-4.51% 608/983 |
12.33% 432/991 |
2.35% 226/1011 |
| 2023 | 6.43% 35/952 |
10.93% 93/880 |
0.14% 182/895 |
-2.54% 183/915 |
-1.69% 206/952 |
| 2022 | -4.41% 35/867 |
-8.89% 85/773 |
7.16% 395/806 |
-6.40% 93/845 |
4.61% 227/867 |
| 2021 | 28.43% 81/740 |
6.80% 33/580 |
16.30% 217/659 |
0.17% 212/704 |
3.23% 292/740 |
| 2020 | 24.36% 369/554 |
-3.41% 244/419 |
17.43% 324/466 |
8.50% 290/517 |
1.05% 480/554 |
| 2019 | 27.13% 303/410 |
25.83% 648/1149 |
-3.93% 645/1231 |
-0.44% 344/390 |
5.64% 327/410 |
| 2018 | -31.18% 233/349 |
- - |
- - |
- - |
-10.29% 315/1080 |
| 2017 | 6.86% 150/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏智胜价值成长A VS. 东吴新产业精选股票A(580008) |